Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder

International Journal of Neuropsychopharmacology

Volumn 9, Issue 2, 2006, Pages 209-213

  Hollander, Eric ^a   Soorya, Latha ^a   Wasserman, Stacey ^a   Esposito, Katherine ^a   Chaplin, William ^b   Anagnostou, Evdokia ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ST JOHN'S UNIVERSITY   (United States)

Author keywords

Autism; Divalproex; Repetitive behaviours; Valproate

Indexed keywords

PLACEBO; VALPROATE SEMISODIUM;

ADOLESCENT; ADULT; AGGRESSION; ANXIETY DISORDER; ARTICLE; AUTISM; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COMPULSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; EVALUATION; HUMAN; IRRITABILITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; STATISTICAL SIGNIFICANCE; STEREOTYPY; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

ADOLESCENT; ADULT; ANTICONVULSANTS; AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PERSONALITY INVENTORY; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; STEREOTYPED BEHAVIOR; TREATMENT OUTCOME; VALPROIC ACID;

EID: 32844464646     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145705005791     Document Type: Article

References (15)

1. Costa E, Grayson DR, Guidotti A (2003). Epigenetic downregulation oi GABAergic function in schizophrenia: Potential for pharmacological intervention? Molecular Intervention 3, 220-229.
2. Dimitropoulous A, Feurer ID, Roof E, Stone E, Butler MG, Sutcliffe J, Thompson T (2000). Appetitive behavior, compulsivity, and neurochemistry in Prader-Willi Syndrome. Mental Retardation and Developmental Disabilities Research Reviews 6, 125-130.
3. Goodman WK, Price LH, Rasmussen SA, Riddle MA, Rappoport JL (1991). Children's Yale-Brown Obsessive-Compulsive Scale (CY-BOCS). New Haven, CT: Clinical Neuroscience Unit.
4. Hollander E (1999). Managing aggressive behavior in patients with obsessive compulsive disorder and borderline personality disorder (1999). Journal of Clinical Psychiatry 60 (Suppl. 15), 38-44.
5. Hollander E, Dolgoff-Kaspar R, Cartwright C, Rawitt R, Novotny S (2001). An open trial of divalproex sodium in autism spectrum disorders. Journal of Clinical Psychiatry 62, 530-534.
6. Hollander E, Posner N, Cherkasky S (2002). Neuropsychiatric aspects of aggression and impulse control disorders. In: Yudofsky SC, Hales RE (Eds.), American Psychiatric Press Textbook of Neuropsychiatry (pp. 579-596). Washington, DC: American Psychiatry Press.
7. Hollander E, Swann A, Coccaro E, Jiang P, Smith TB (2005). Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder. American Journal of Psychiatry 162, 621-624.
8. Hollander E, Tracy K, Swann A, Coccaro E, McElroy S, Wozniak P, Sommerville K, Nemeroff C (2003). Divaproex in the treatment of impulsive aggression: efficacy in Cluster B Personality disorders. Neuropsychopharmacology 28, 1186-1197.
9. Johnson BA, Ait-Daoud N, Bowden CL, DiClemente CC, Roache JD, Lawson K, Javors MA, Ma JZ (2003). Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet 361, 1677-1685.
10. McElroy SL, Shapira NA, Arnold LM, Keck PE, Rosenthal NR, Wu SC, Capece JA, Fazzio L, Hudson JI (2004). Topiramate in the long-term treatment of binge-eating disorder associated with obesity. Journal of Clinical Psychiatry 65, 1463-1469.
11. Pallanti S, Quercioloi L, Sood E, Hollander E (2002). Lithium and valproate treatment of pathological gambling: a randomized, single-blind study. Journal of Clinical Psychiatry 63, 559-564.
12. Smathers SA, Wilson JG, Nigro MA (2003). Topiramate effectiveness in Prader-Willi syndrome. Pediatric Neurology 28, 130-133.
13. Soderpalm B (2002). Anticonvulsants: aspects of their mechanisms of action. European Journal of Pain 6 (Suppl. A), 3-9.
14. Veltman MWM, Thompson RJ, Roberts SE, Thomas NS, Whittington J, Bolton PF (2004). Prader-Willi syndrome: a study comparing deletion and uniparental disomy cases with reference to autism spectrum disorders. European Child & Adolescent Psychiatry 13, 42-50.
15. Yang P, Beasley A, Eckermann K, Swann A, Dafny N (2000). Valproate prevents the induction of sensitization to methylphenidate (ritalin) in rats. Brain Research 887, 276-284.